Healthcare Startup Laboratoy work visual


The BaseLaunch accelerator supports carefully selected ventures over the course of 15 months and runs in two phases. It provides non-dilutive funding, no strings attached access to its Healthcare Partners, knowledge from highly experienced advisors, as well as a state-of-the-art infrastructure. Furthermore, Baselaunch embeds the ventures deeply within the Basel region, one of Europe’s finest biotech ecosystem. Baselaunch is backed by five industry leaders — Johnson & Johnson Innovation, Novartis Venture Fund, Pfizer, Roche and Roivant Sciences — as well as by other public and private partners.


BaseLaunch was launched in 2017 as an initiative of, the innovation and economic promotion agency for the region of Basel, which oversees and manages the operations of BaseLaunch. Through its extensive network of decision-makers, innovators and experts, supports entrepreneurs and companies from abroad with the successful implementation of innovation and business ventures in the Basel region.


The next cycle starts in September 2018 and runs in two phases through December 2019. Applications for the 2019 cycle can be submitted now.

Basel region: leading life sciences hub

The Basel region is home to headquarters of Roche and Novartis, two of the world’s biggest pharma companies. Additionally, Johnson and Johnson has operations in the region through its recent 30 billion dollars acquisition of Actelion, formerly Europe’s biggest biotech. Also, newly formed Actelion spin-off Idorsia as well as numerous other successful biopharma companies are based here. World-class biomedical research institutions such as the ETH Zürich, with its Department of Biosystems Science and Engineering, the Biozentrum of the University of Basel, the Friederich Miescher Institute for Biomedical Research, the Department of Biomedicine of the University and the Life Sciences Branch of the University of Applied Sciences and Arts are based here.


This tightly interwoven academic and industrial Environment with the availability of venture capital from top-tier investors such as the Novartis Venture Fund, Versant Ventures and the Roche Venture Fund provides the ideal breeding ground for the creation of new companies. In addition, there is a very active and highly experienced business angel community, with a track record in the pharma and biotech industry and an eagerness to invest in new companies. Thanks to this vibrant entrepreneurial healthcare environment, the Basel region has become a hotspot for biotech companies such as Cellestia biotech, Polyphor, Nouscom, Basilea, Santhera and many more.


BaseLaunch is deeply embedded within the Basel region ecosystem and provides access to what matters when starting and building a healthcare company: Talents and specialists from all fields, including research, regulatory, clinical, intellectual property, legal, finance and manufacturing as well as access to various sources of financing.


For more information on the Basel region as a business location, please visit, northwestern Switzerland’s joint initiative for innovation and economic promotion by the cantons of Basel-Stadt, Basel-Landschaft and Jura.

Biotech Office Buildings